NCT05858801View on ClinicalTrials.gov

First Evaluation of a Craniofacial Peripheral Nerve Stimulation System in Chronic Migraine

NAActive, not recruitingINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

May 9, 2023

Primary Completion Date

December 9, 2023

Study Completion Date

January 31, 2026

Conditions
Chronic Migraine
Interventions
DEVICE

PRIMUS

PRIMUS system

Trial Locations (1)

Unknown

AZ Delta, Roeselare

Sponsors
All Listed Sponsors
lead

Salvia BioElectronics

INDUSTRY

NCT05858801 - First Evaluation of a Craniofacial Peripheral Nerve Stimulation System in Chronic Migraine | Biotech Hunter | Biotech Hunter